.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Progesterone - Generic Drug Details

« Back to Dashboard
Progesterone is the generic ingredient in five branded drugs marketed by Bionpharma Inc, Allergan Sales Llc, Fresenius Kabi Usa, Teva Pharms, Hikma Farmaceutica, Lilly, Luitpold, Alza, Sofgen Pharms, Ferring, and Virtus Pharms, and is included in twelve NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has eleven patent family members in nine countries.

There are forty-nine drug master file entries for progesterone. Twenty-one suppliers are listed for this compound.

Summary for Generic Name: progesterone

Tradenames:5
Patents:3
Applicants:11
NDAs:12
Drug Master File Entries: see list49
Suppliers / Packaging: see list21
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Drug Prices:see low prices

Pharmacology for Ingredient: progesterone

Ingredient-typeProgesterone
Drug ClassProgesterone

Clinical Trials for: progesterone

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms
PROGESTERONE
progesterone
CAPSULE;ORAL202121-001Feb 29, 2012RXNo
Ferring
ENDOMETRIN
progesterone
INSERT;VAGINAL022057-001Jun 21, 2007RXYes7,393,543Nov 17, 2019Y
Alza
PROGESTASERT
progesterone
INSERT, EXTENDED RELEASE;INTRAUTERINE017553-001Approved Prior to Jan 1, 1982DISCNNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: progesterone

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Sales Llc
CRINONE
progesterone
GEL;VAGINAL020701-001Jul 31, 19974,615,697<disabled>
Allergan Sales Llc
CRINONE
progesterone
GEL;VAGINAL020701-002Jul 31, 19975,543,150<disabled>
Allergan Sales Llc
CRINONE
progesterone
GEL;VAGINAL020701-002Jul 31, 19974,615,697<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: progesterone

Country Document Number Estimated Expiration
Japan2002529494<disabled in preview>
Israel127129<disabled in preview>
European Patent Office1131052<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: PROGESTERONE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0037Belgium<disabled>PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc